28.7% swing bad news for Target Corp. (TGT:NYQ) stocks

0Comments

Target Corp. (TGT:NYQ) saw one of the biggest daily changes on Wall Street, down 28.7 percent throughout the day.

It fell $61.85, placing it ninth among the top 50 biggest swings in Wall Street during the time frame.

Shares in Target Corp. finished on May 19 at $153.43.

Target Corp. employs 450,000 people and has reported $5,860,000,000 USD in income.

Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.

Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.

Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”

Nothing in this article is to be assumed as financial advice.

Top 50 biggest stock market swings on May 19

Company Name Percentage Change Current Trading Price
NeuroMetrix Inc. 76.3% $5.5
ACRO Biomedical Co. Ltd. 49% $3.8
VivoPower International PLC 42.3% $1.58
Vestin Realty Mortgage I Inc. 42.2% $3
Rapid Therapeutic Science Laboratories Inc. 41.9% $4.4
Triumph Group Inc. -34.9% $14.25
TORtec Group Corp. -32.7% $1.01
Bio Lab Naturals Inc. -30.3% $1.08
Target Corp. -28.7% $153.43
Western Capital Resources Inc. -27.7% $5.3
Immix Biopharma Inc. 25.4% $1.63
Uniroyal Global Engineered Products Inc. -23.7% $1.22
HG Holdings Inc. 23.5% $10
Oncology Institute Inc. 22.7% $7.58
Artemis Therapeutics Inc. 22.3% $3.9
IMAC Holdings Inc. 22.3% $1.04
Tenaya Therapeutics Inc. -22.3% $5.62
Under Armour Inc. -21.6% $8.18
Concrete Leveling Systems Inc. 21.6% $3.89
Chimerix Inc. 21.5% $2.2
NanoViricides Inc. 20.9% $1.85
Sellas Life Sciences Group Inc. 20.8% $3.6
Woodbridge Liquidation Trust 20.3% $8
Cellectis SA 20.2% $3.93
Unico American Corp. 20.2% $2.2
Talaris Therapeutics Inc. -20.1% $7.1
Arax Holdings Corp. -20% $1
Innovative Medtech Inc. -19.4% $1.45
Biotricity Inc. 18.8% $1.33
Indaptus Therapeutics Inc. 18.8% $2.97
SIGA Technologies Inc. 18.8% $8.65
Nanomix Corp. -18.7% $1
Under Armour Inc. -18.6% $9.28
Immunome Inc. 18% $3.35
CreditRiskMonitor.Com Inc. -17.8% $2.26
Tecogen Inc. 17.8% $1.59
Sweetgreen Inc. 17.5% $22.23
Shoe Carnival Inc. -17.3% $26.24
Repay Holdings Corp. 16.8% $12.73
Ekimas Corp. 16.7% $1.75
Codiak BioSciences, Inc. 16.5% $3.39
Surgery Partners Inc. -16.5% $38.79
Clear Secure Inc. -16.2% $28.79
Biomea Fusion Inc. 16.2% $6.03
Dynavax Technologies Corp. 16.2% $11.18
IZEA Worldwide Inc. 16% $1.07
Alpha Teknova Inc. -16% $8.93
Yellow Corp. -16% $3.63
TherapeuticsMD Inc. -15.9% $2.27
Marpai Inc. 15.4% $1.57


Related

Dalia al-Aqidi challenges Rep. Ilhan Omar, calling for an investigation into Omar’s reported multimillion-dollar wealth amid Minnesota’s  billion welfare fraud investigation.

al-Aqidi suggests investigation of Omar’s wealth: ‘Transparency is not optional for elected officials’

Dalia al-Aqidi, a former U.S. Army officer and Republican candidate for Minnesota’s 5th Congressional District, is calling for a federal investigation into Rep. Ilhan Omar’s reported multimillion-dollar family wealth amid the ongoing $9 billion welfare fraud investigation in the state.

Dr. Katherine Crawford Luber Mia’s Nivin and Duncan MacMillan Director & President

Minneapolis Institute of Art announces major German modern art exhibition for spring 2026

The Minneapolis Institute of Art (Mia) will present a major international exhibition titled “Modern Art and Politics in Germany 1910–1945: Masterworks from the Neue Nationalgalerie, Berlin.” The exhibition is scheduled to run from March 7 through…

Dr. Katherine Crawford Luber Mia’s Nivin and Duncan MacMillan Director & President

Minneapolis Institute of Art announces Norwegian silver exhibition tracing three centuries

The Minneapolis Institute of Art (Mia) will present a new exhibition titled “Crowning the North: Silver Treasures from Bergen, Norway” from November 15, 2025, through March 8, 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Minneapolis Review.